期刊文献+

氨溴特罗口服液治疗小儿支气管肺炎的疗效观察 被引量:17

Observation of curative effect of ammonia bromine oral liquid in the treatment of children with bronchial pneumonia
下载PDF
导出
摘要 目的探讨氨溴特罗口服液治疗小儿支气管肺炎的疗效。方法 78例患儿随机分为两组,观察组采用氨溴特罗口服液治疗,对照组采用盐酸氨溴索颗粒治疗,比较两组疗效、咳嗽咳痰评分和免疫指标变化。结果观察组有效率89.74%,对照组71.79%,观察组疗效优于对照(Ridit z=48.478,P=0.000);治疗3 d后观察组咳嗽、咳痰情况优于对照(P<0.05);两组IgG差异有统计学意义(P<0.05)。结论氨溴特罗口服液治疗小儿支气管肺炎起效快,且能调理患儿免疫功能,值得临床推广和应用。 Objective To study the curative effect of ammonia bromine oral liquid in the treatment of chil dren with bronchial pneumonia. Methods 78 children with bronchial pneumonia were randomly divided into two groups. The observation group was treated with ammonia bromine oral liquid, and the control group was given hydro chloric acid ammonia bromine granules treatment. The curative effect, cough and expectoration score and immune in dex changes were observed. Results The effective rate was 89.74% in the observation group and 71.79% in the control group ( Ridit z = 48.478, P = 0. 000). The improvement of cough and expectoration 3 days after the treatment was more pronounced in the observation group than in the control group ( P 〈 0. 05 ). There was significant difference in IgG between the two groups ( P 〈 0. 05 ). Conclusion Ammonia bromine oral liquid has fast curative effect in the treatment of children with bronchial pneumonia, and it can regulate their immune function.
作者 张士勇
出处 《临床肺科杂志》 2014年第3期481-483,共3页 Journal of Clinical Pulmonary Medicine
关键词 氨溴特罗口服液 支气管肺炎 盐酸氨溴索颗粒 ammonia bromine oral liquid bronchial pneumonia hydrochloric acid ammonium bromide ca-ble granule
  • 相关文献

参考文献10

二级参考文献40

共引文献57

同被引文献128

  • 1洪建国,李云珠,陆权,张灵恩,王立波,李臻,邵洁,钟文伟,陆敏,任慈芳,俞善昌.氨溴特罗口服液改善支气管炎患儿呼吸道症状临床疗效观察[J].中国实用儿科杂志,2006,21(1):63-65. 被引量:102
  • 2章礼真.氨溴特罗口服液治疗小儿肺炎临床疗效观察[J].临床肺科杂志,2007,12(2):124-125. 被引量:12
  • 3郑军.双氯芬酸钠栓与对乙酰氨基酚栓治疗小儿急性发热对比分析[J].儿科药学杂志,2007,13(6):21-23. 被引量:4
  • 4Li XH, Zhang J. Azithromycin in the treatment of 42 cases of children bronchial pneumonia effect analysis [ J ]. China Herald of Medicine, 2009,17 ( 2 ) :291-293.
  • 5Lee JY, Hwang SJ, Shim JW, et al. Clinical significance of serum pro-calcitonin in patients with community-acquired lobar pneumonia [ J ]. Korean J Lab Med,2010,30( 1 ) :406-413.
  • 6Nakamura A, Wada H, Ikejiri M, et al. Efficacy of proealcitonin in the eady diagnosis of bacterial infections in a critical care unit [ J ]. Shock, 2009,31 (6) ,586-591.
  • 7Chub AA, Molinarl N,Sciallis G, et al. Temporal case clustering in pit- yriasis rosea:aregression analysis on 1379 patients in Minnesota,Kuwait and Diyarbakir,Turkey[ J]. Arch Dermato1,2005,141 (4) :767.
  • 8Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy [J]. Respir Med, 1998, 92(4) :609.
  • 9Zuber A, Rakesh B, Deepak P, et al. A comparative eval- uation of efficacies of three inhaled drugs viz salbuta- mol,n-acetylcysteine,and ambroxol in terms of sputum induction and AFB positivity in AFB negative pulmonary tuberculosis cases [J]. Chest, 2011,140 (10) : 788A.
  • 10Malerba M, Ponticiello A, Radaeli A, et al. Ambroxol and reduction of COPD exacerbations [J]. Thorax,2004,59(4) : 334.

引证文献17

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部